Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SERA PROGNOSTICS, INC.SERA · Entity 304 | Director | July 10, 2026 | July 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SERA PROGNOSTICS, INC.
Report date July 10, 2026 · Filed July 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 846,886 |
Ending reported balance
After 2026-07-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-07-10 · Grant · Acquired 22,426 · Balance 845,292 F1: Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. Row 2 · 2026-07-10 · Grant · Acquired 1,594 · Balance 846,886 F2: Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.97 · Expires 2036-07-10 | Direct | 34,494 |
Reported balance
After 2026-07-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-10 · Grant · Acquired 34,494 · Balance 34,494 F3: Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.97 · Expires 2036-07-10 | Direct | 2,452 |
Reported balance
After 2026-07-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-07-10 · Grant · Acquired 2,452 · Balance 2,452 F4: These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer.
F2: Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer.
F3: Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer.
F4: These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 10, 2026 Filed Jul 14, 2026 22:41 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantStock Option (right to buy) · Derivative | 2,452 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0001191080-26-000002 · ownership.xml · derivative · entry 4 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,452 Underlying: Class A Common Stock · 2,452 shares Expires 2036-07-10 F4 · derivative.exercise_date: These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. Read SEC document |
| July 10, 2026 Filed Jul 14, 2026 22:41 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantStock Option (right to buy) · Derivative | 34,494 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0001191080-26-000002 · ownership.xml · derivative · entry 3 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,494 Underlying: Class A Common Stock · 34,494 shares Expires 2036-07-10 F3 · derivative.exercise_date: Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. Read SEC document |
| July 10, 2026 Filed Jul 14, 2026 22:41 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantClass A Common Stock | 1,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001191080-26-000002 · ownership.xml · nonDerivative · entry 2 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 846,886 F2 · shares: Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. Read SEC document |
| July 10, 2026 Filed Jul 14, 2026 22:41 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantClass A Common Stock | 22,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001191080-26-000002 · ownership.xml · nonDerivative · entry 1 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 845,292 F1 · shares: Each share is represented by a restricted stock unit ("RSU") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 22:38 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0000950170-25-083334 · ownership.xml · derivative · entry 2 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2035-06-05 F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 5, 2025. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 22:38 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantClass A Common Stock | 15,596 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-083334 · ownership.xml · nonDerivative · entry 1 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 822,866 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 5, 2025, subject to the Reporting Person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantStock Option (right to buy) · Derivative | 10,549 | $0.00 Strike: $8.43 | $0.00 |
DisclosureSEC source: 0001534969-24-000136 · wk-form4_1717792347.xml · derivative · entry 2 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,549 Underlying: Class A Common Stock · 10,549 shares Expires 2034-06-06 F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantClass A Common Stock | 7,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000136 · wk-form4_1717792347.xml · nonDerivative · entry 1 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807,270 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | OtherClass A Common Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000120 · wk-form4_1717634121.xml · nonDerivative · entry 2 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,153 F3 · kind: Pro rata distribution from Catalyst Health Ventures (PF) L.P., of which the Reporting Person is a non-managing member. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | OtherClass A Common Stock | 195 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000120 · wk-form4_1717634121.xml · nonDerivative · entry 1 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,140 F1 · kind: Pro rata distribution from Catalyst Health Ventures, L.P., of which the Reporting Person is a non-managing member. F2 · balance_after: The Reporting Person purchased 5,000 shares of Class A Common Stock pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of December 1, 2022 to May 31, 2023. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 00:49 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantStock Option (right to buy) · Derivative | 98,300 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001534969-23-000012 · wf-form4_167823653736339.xml · derivative · entry 2 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,300 Underlying: Class A Common Stock · 98,300 shares Expires 2033-03-07 F2 · derivative.exercise_date: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the vesting commencement date, which is March 7, 2023, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 00:49 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantClass A Common Stock | 62,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-23-000012 · wf-form4_167823653736339.xml · nonDerivative · entry 1 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 857,145 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 1/4 of the original grant amount vests in annual installments for four years following the vesting commencement date, which is March 7, 2023, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 20:36 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantStock Option (right to buy) · Derivative | 429,225 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001534969-22-000023 · wf-form4_164824052547856.xml · derivative · entry 1 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,225 Underlying: Class A Common Stock · 429,225 shares Expires 2032-03-23 F1 · derivative.exercise_date: These stock options vest over four years beginning on the grant date of March 23, 2022 as follows: 15% of the original grant amount vests in equal monthly installments over the first year following the grant date, 20% of the original grant amount vests in equal monthly installments over the second year following the grant date, 25% of the original grant amount vests in equal monthly installments over the third year following the grant date, and 40% of the original grant amount vests in equal monthly installments over the fourth year following the grant date, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionSeries D Preferred Stock · Derivative | 28,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · derivative · entry 10 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 28,730 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Issuer's Series D Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $9.02 per share. The Series D Preferred Stock has no expiration date. F7 · derivative.exercise_date: The shares of preferred stock automatically converted into the Issuer's Class A Common Stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering, which became effective on July 19, 2021. F6 · derivative.expiration_date: The Issuer's Series D Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $9.02 per share. The Series D Preferred Stock has no expiration date. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionSeries C-1 Preferred Stock · Derivative | 4,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · derivative · entry 9 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Issuer's Series C-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $12.37 per share. The Series C-1 Preferred Stock has no expiration date. F7 · derivative.exercise_date: The shares of preferred stock automatically converted into the Issuer's Class A Common Stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering, which became effective on July 19, 2021. F5 · derivative.expiration_date: The Issuer's Series C-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $12.37 per share. The Series C-1 Preferred Stock has no expiration date. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionSeries B-2 Preferred Stock · Derivative | 11,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · derivative · entry 8 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 11,880 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Issuer's Series B-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $8.32 per share. The Series B-2 Preferred Stock has no expiration date. F7 · derivative.exercise_date: The shares of preferred stock automatically converted into the Issuer's Class A Common Stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering, which became effective on July 19, 2021. F4 · derivative.expiration_date: The Issuer's Series B-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $8.32 per share. The Series B-2 Preferred Stock has no expiration date. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionSeries B-1 Preferred Stock · Derivative | 5,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · derivative · entry 7 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,253 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Issuer's Series B-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series B-1 Preferred Stock has no expiration date. F7 · derivative.exercise_date: The shares of preferred stock automatically converted into the Issuer's Class A Common Stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering, which became effective on July 19, 2021. F3 · derivative.expiration_date: The Issuer's Series B-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series B-1 Preferred Stock has no expiration date. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionSeries A-2 Preferred Stock · Derivative | 34,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · derivative · entry 6 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 34,383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's Series A-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series A-2 Preferred Stock has no expiration date. F7 · derivative.exercise_date: The shares of preferred stock automatically converted into the Issuer's Class A Common Stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering, which became effective on July 19, 2021. F1 · derivative.expiration_date: The Issuer's Series A-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series A-2 Preferred Stock has no expiration date. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionClass A Common Stock | 28,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · nonDerivative · entry 5 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 794,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: The Issuer's Series D Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $9.02 per share. The Series D Preferred Stock has no expiration date. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionClass A Common Stock | 4,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · nonDerivative · entry 4 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: The Issuer's Series C-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $12.37 per share. The Series C-1 Preferred Stock has no expiration date. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionClass A Common Stock | 11,880 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · nonDerivative · entry 3 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The Issuer's Series B-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $8.32 per share. The Series B-2 Preferred Stock has no expiration date. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionClass A Common Stock | 5,253 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · nonDerivative · entry 2 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Issuer's Series B-1 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series B-1 Preferred Stock has no expiration date. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:01 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionClass A Common Stock | 34,383 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094519 · tm2122781-3_4seq1.xml · nonDerivative · entry 1 CRITCHFIELD GREGORY C · CIK 0001191080 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 744,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's Series A-2 Preferred Stock is convertible at the option of a holder at any time into shares of the Issuer's Class A Common Stock at a conversion price, as adjusted to reflect the Issuer's recent 1-for-0.481 reverse stock split, of $5.20 per share. The Series A-2 Preferred Stock has no expiration date. F2 · balance_after: Includes 630,832 shares of Class A Common Stock directly held by The Gregory C. Critchfield & Trust. Dr. Critchfield is a Trustee of the Gregory C. Critchfield & Trust. Dr. Critchfield, in such capacity, may be deemed to indriectly beneficially own the securities owned by the trust except to the extent of his pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.